Oncimmune Holdings plc focuses on the development of immune profiling technologies for cancer detection. The company aims to provide innovative diagnostic solutions to improve early detection and treatment options.
1998
United Kingdom
11 - 50 employees
Biotechnology
$1M - 10M in revenue
Not profitable